TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Fetal bovine serum Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Product Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Charcoal Stripped
4.2.1 Market Size & Forecast (Value)
4.3 Chromatographic
4.3.1 Market Size & Forecast (Value)
4.4 Dialyzed Fetal Bovine Serum (FBS)
4.4.1 Market Size & Forecast (Value)
4.5 Exosome Depleted
4.5.1 Market Size & Forecast (Value)
4.6 Stem Cell
4.6.1 Market Size & Forecast (Value)
4.6.2 Embryonic Stem Cells Qualified
4.6.3 Mesenchymal Stem Cell Qualified
4.6 Others
5 End-user Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Research & Academic Institutes
5.2.1 Market Size & Forecast (Value)
5.3 Industry
5.3.1 Market Size & Forecast (Value)
5.3.2 Pharmaceutical industry
5.3.3 Biotechnological industry
6 Application Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 Drug Discovery
6.2.1 Market Size & Forecast (Value)
6.3 Cell Culture Media
6.3.1 Market Size & Forecast (Value)
6.4 In vitro Fertilization
6.4.1 Market Size & Forecast (Value)
6.5 Human and Animal Vaccine production
6.5.1 Market Size & Forecast (Value)
6.6 Diagnostics
6.6.1 Market Size & Forecast (Value)
6.7 Others
6.7.1 Market Size & Forecast (Value)
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Product
7.2.1.1.2 By Application
7.2.1.2 Canada
7.2.1.2.1 By Product
7.2.1.2.2 By Application
7.2.1.3 Mexico
7.2.1.3.1 By Product
7.2.1.3.2 By Application
7.2.4 Latin America
7.2.4.1 By Product
7.2.4.2 By Application
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Germany
7.3.2.1 By Product
7.3.2.2 By Application
7.3.3 France
7.3.3.1 By Product
7.3.3.2 By Application
7.3. 4 U.K
7.3.4.1 By Product
7.3.4.2 By Application
7.3.5 Italy
7.3.5.1 By Product
7.3.5.2 By Application
7.3.6 Spain
7.3.6.1 By Product
7.3.6.2 By Application
7.3.7 Rest of Europe
7.3.7.1 By Product
7.3.7.2 By Application
7.4 Asia Pacific
7.4.1 Market Size & Forecast (Value)
7.4.2 Japan
7.4.2.1 By Product
7.4.2.2 By Application
7.4.3 China
7.4.3.1 By Product
7.4.3.2 By Application
7.4.4 Australia
7.4.4.1 By Product
7.4.4.2 By Application
7.4.5 India
7.4.5.1 By Product
7.4.5.2 By Application
7.4.6 South Korea
7.4.6.1 By Product
7.4.6.2 By Application
7.4.7 Rest of Asia-Pacific
7.4.7.1 By Product
7.4.7.2 By Application
7.5 Middle East & Africa
7.5.1 Market Size & Forecast (Value)
7.5.2 Saudi Arabia
7.5.2.1 By Product
7.5.2.2 By Application
7.5.3 South Africa
7.5.3.1 By Product
7.5.3.2 By Application
7.5.4 Kwait
7.5.4.1 By Product
7.5.4.2 By Application
7.5.5 Rest of Middle East & Africa
7.5.5.1 By Product
7.5.5.2 By Application
8 Company Profile
8.1 Thermo Fisher Scientific Inc.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Atlanta Biologicals Inc.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Tissue Culture Biologicals
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 HiMedia Laboratories
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 Bovogen Biologicals Pty Ltd.
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 TCS Biosciences Ltd.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 Rocky Mountain Biologicals
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
8.8 GE Healthcare
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Recent Developments
8.8.4 Product Portfolio
8.9 PAN-Biotech
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Recent Developments
8.9.4 Product Portfolio
